BeiGene Names New President and China GM
BeiGene Ltd. (Nasdaq: BGNE), a biotech company based in Beijing and Cambridge, Mass., announced it appointed Xiaobin Wu as General Manager of China and President of BeiGene. Wu will report to John Oyler, founder, CEO and chairman, the company said. Before joining BeiGene, Wu served as Country Manager at Pfizer China since 2009. He was previously President and Managing Director of Wyeth China and Hong Kong. With more than 1,100 employees in China, the U.S., and Australia, BeiGene focusses on developing immuno-oncology cancer therapies.